Nanotechnology RSS feeds

ENJOY THE BENEFITS

Simply Register to GAIN ACCESS to lots more info

USER LOGIN


copyright-Nanovip 2008

NANO FACTS

...Nanometres...
nanotechnology companies | nanotechnology info Human hair 80,000 nm wide
nanotechnology companies | nanotechnology info Red blood cell 7,000 nm wide
nanotechnology companies | nanotechnology info Water molecule 0.3 nm wide
nanotechnology companies | nanotechnology info Sheet Paper 100,000 nm wide

PRODUCTS

LATEST MEMBERS

  • lidgan
  • timada
  • Pedro ALQ
  • budz44
  • phnsamarasinghe
  • abanderas

WHO'S ONLINE

There are currently 0 users and 14 guests online.

  Valid XHTML 1.0 Transitional

Button for your site

ARVO : Nanotechnology and Nanomedicine: Applications for Vision course


   




KEEP UPDATED WITH NANOVIP CONTENT - USE OUR RSS FEEDS HERE

*** NEWS *** - OUR SISTER SITE IS LAUNCHED - Jobs, News, Comments and more NanoBroadcast.com
Address: The Association for Research in Vision and Ophthalmology (ARVO), 12300 Twinbrook Parkway, Suite 250
Zip: 20852-1606

Visit this link

Phone :
240-221-2900

Fax :
240-221-0370

Organized by Drs. Paul Sieving and Richard Fisher of the NEI, the course features streaming video of speakers with their corresponding PowerPoint presentation slides. The seven-presentation course runs approximately three hours. Each presentation can be viewed separately and ranges from seven to 35 minutes in length. A online transcript of the course is also available.

The course introduces fundamental concepts, including changes in the properties of materials at the nanoscale, and the potential of nanotechnology and its application to biomedical sciences. The underlying physical sciences, conveyed by renowned experts in nanoscience, are emphasized and the course includes examples of NEI-funded studies of either applied or fundamental nanoscience in vision research.

» | Edit this entry
                                                                                                                                                                                                                                                                                          
Back to previous page Go to the top of this page